Skip to main content

Published locations for Cabozantinib used as first-line therapy prolongs PFS for metastatic RCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Cabozantinib used as first-line therapy prolongs PFS for metastatic RCC

User login

  • Reset your password
  • /content/cabozantinib-used-first-line-therapy-prolongs-pfs-metastatic-rcc
  • /oncologypractice/article/115732/genitourinary-cancer/cabozantinib-used-first-line-therapy-prolongs
  • /hematology-oncology/article/115732/genitourinary-cancer/cabozantinib-used-first-line-therapy